Literature DB >> 4041681

Electrophysiological actions of nicotine on substantia nigra single units.

P B Clarke, D W Hommer, A Pert, L R Skirboll.   

Abstract

Extracellular recordings of single unit activity were made in the substantia nigra (SN) of chloral hydrate-anaesthetized rats. Dopaminergic neurones of the pars compacta (SNC) were stimulated by (-)-nicotine bitartrate (1.0 mg kg-1) given subcutaneously (s.c.). This action was prevented by the secondary amine mecamylamine HCl (2.0 mg kg-1 i.v.) but not by a ganglion-blocking dose of the bisquaternary compound chlorisondamine Cl (0.1 mg kg-1 i.v.). Mecamylamine reduced the spontaneous activity of dopaminergic neurones. Nicotine, when administered intravenously (2-128 micrograms kg-1 cumulative dose), also stimulated dopamine cells and this action was dose-related. Nicotine, administered intravenously, (2-128 micrograms kg-1 cumulative dose) markedly excited non-dopamine cells in the pars reticulata (SNR) in a dose-related manner. In rats pretreated with chlorisondamine (0.1 mg kg-1 i.v.), nicotine induced a small excitatory or depressant action, but the marked excitation was not seen. Mecamylamine (2 mg kg-1 i.v.) completely prevented the actions of nicotine. The results are consistent with a direct excitatory action of nicotine on dopaminergic neurones of the substantia nigra pars compacta. The pronounced excitatory action of systemically administered nicotine on non-dopamine cells of the pars reticulata appears to be of peripheral origin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041681      PMCID: PMC1916681          DOI: 10.1111/j.1476-5381.1985.tb11081.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.

Authors:  F Javoy; Y Agid; D Bouvet; J Glowinski
Journal:  Brain Res       Date:  1974-03-22       Impact factor: 3.252

2.  Stereotyped behaviour after cholinergic, but not dopaminergic, stimulation of the substantia nigra in rats.

Authors:  L Decsi; J Nagy; K Zámbó
Journal:  Life Sci       Date:  1978-06-05       Impact factor: 5.037

3.  Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons.

Authors:  A A Grace; B S Bunney
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

4.  The localization of receptor binding sites in the substantia nigra and striatum of the rat.

Authors:  T D Reisine; J I Nagy; K Beaumont; H C Fibiger; H I Yamamura
Journal:  Brain Res       Date:  1979-11-16       Impact factor: 3.252

5.  The uptake of 3H-choline and release of 3H-acetylcholine in the rat substantia nigra.

Authors:  S C Massey; T A James
Journal:  Life Sci       Date:  1978-07-24       Impact factor: 5.037

6.  Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra.

Authors:  C E Ribak; J E Vaughn; K Saito; R Barber; E Roberts
Journal:  Brain Res       Date:  1976-11-05       Impact factor: 3.252

7.  Dopaminergic activation of reticulata neurones in the substantia nigra.

Authors:  A Ruffieux; W Schultz
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

8.  Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra.

Authors:  P G Guyenet; G K Aghajanian
Journal:  Brain Res       Date:  1978-07-07       Impact factor: 3.252

9.  Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.

Authors:  L Ahtee; S Kaakkola
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

10.  Evidence that a nigral gabaergic--cholinergic balance controls posture.

Authors:  G M De Montis; M C Olianas; G Serra; A Tagliamonte; J Scheel-Krüger
Journal:  Eur J Pharmacol       Date:  1979-01-01       Impact factor: 4.432

View more
  28 in total

1.  Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra.

Authors:  M M Arroyo-Jim nez; J P Bourgeois; L M Marubio; A M Le Sourd; O P Ottersen; E Rinvik; A Fairén; J P Changeux
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 2.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 3.  Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.

Authors:  Paul R Sanberg; Cecilia Vindrola-Padros; R Douglas Shytle
Journal:  Physiol Behav       Date:  2012-07-06

Review 4.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

5.  Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.

Authors:  Vincenzo Di Matteo; Massimo Pierucci; Arcangelo Benigno; Ennio Esposito; Giuseppe Crescimanno; Giuseppe Di Giovanni
Journal:  CNS Neurosci Ther       Date:  2010-03-25       Impact factor: 5.243

Review 6.  Molecular studies of the neuronal nicotinic acetylcholine receptor family.

Authors:  J Lindstrom; R Schoepfer; P Whiting
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

7.  Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease.

Authors:  F Takakubo; M Yamamoto; N Ogawa; Y Yamashita; Y Mizuno; I Kondo
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder.

Authors:  Alexandra S Potter; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

9.  Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.

Authors:  P Whiteaker; H S Garcha; S Wonnacott; I P Stolerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.